SCHEMBL2029031

SCHEMBL2029031

Oc1ccccc1N=Cc1c(O)ccc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 14/20 1.00
▸ MEN1 O00255 12/20 1.00
▸ MAPT P10636 10/20 1.00
▸ GAA P10253 7/20 1.00
▸ ALDH1A1 P00352 6/20 1.00
▸ KDM4E B2RXH2 5/20 1.00
▸ L3MBTL1 Q9Y468 4/20 1.00
▸ ATM Q13315 1/20 1.00
▸ POLB P06746 4/20 0.75
▸ THRB P10828 4/20 0.65
▸ BLM P54132 1/20 0.65
▸ CASP6 P55212 1/20 0.65
▸ CRHBP P24387 1/20 0.60
▸ CRHR2 Q13324 1/20 0.60
▸ HPGD P15428 3/20 0.58
▸ RRM1 P23921 1/20 0.58
▸ LMNA P02545 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ GLA P06280 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2029030 1.00 KMT2A (1.00) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL29785654 1.00 KMT2A (1.00) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL31301126 1.00 KMT2A (1.00) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL16323254 0.98 KMT2A (0.97) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL23761140 0.93 KMT2A (0.87) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL28039588 0.90 KMT2A (0.82) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL9179463 0.86 KMT2A (0.75) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL9179465 0.86 KMT2A (0.75) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL11895330 0.86 KMT2A (0.75) KMT2AMEN1MAPTGAAALDH1A1
SCHEMBL10049041 0.85 KMT2A (0.74) KMT2AMEN1MAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131561-A1 COLORING COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-04-27 — — US disclosed
US-20230131561-A1 COLORING COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-04-27 — — US disclosed
US-20230126240-A1 COLORING COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-04-27 — — US disclosed
US-20220390837-A1 COLORING COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2022-12-08 — — US disclosed
EP-2504418-B1 DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU HENKEL AG & CO KGAA (DE) 2017-02-15 — — EP disclosed
US-8481475-B2 Detergents or cleaning agents containing a bleach-enhancing transition metal complex which is optionally produced in situ HENKEL AG & CO. KGAA (DE) 2013-07-09 — — US disclosed
US-8383673-B2 Nitridoosmium(VI) complexes for treatment of cancer CITY UNIVERSITY OF HONG KONG (HK) 2013-02-26 — — US disclosed
US-20120264670-A1 DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU HENKEL AG & CO. KGAA (US) 2012-10-18 — — US disclosed
EP-2504418-A1 DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU Henkel AG & Co. KGaA (DE) 2012-10-03 — — EP disclosed
US-20110230456-A1 Nitridoosmium(VI) Complexes for Treatment of Cancer THE CITY UNIVERSITY OF HONG KONG (HK) 2011-09-22 — — US disclosed
WO-2011064159-A1 DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU HENKEL AG & CO. KGAA (DE) 2011-06-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230456-A1 Nitridoosmium(VI) Complexes for Treatment of Cancer NPM1, IDH2, MT-ND5 KMT2A 2641/4885MEN1 594/4885MAPT 3469/4885
US-20120264670-A1 DETERGENTS OR CLEANING AGENTS CONTAINING A BLEACH-ENHANCING TRANSITION METAL COMPLEX WHICH IS OPTIONALLY PRODUCED IN SITU DSG1, MPO, MFAP1 KMT2A 1287/4885MEN1 83/4885MAPT 2059/4885
US-20230131561-A1 COLORING COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT AND IMAGE DISPLAY DEVICE SF1, SPIN1, RER1 KMT2A 1460/4885MEN1 421/4885MAPT 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback